Skip to content
Mesothelioma.net
phone iconCall1-800-692-8608 chat icon Chat 24/7 Live Chat
Menu
  • Malignant Mesothelioma
    • About Mesothelioma
      • How to Survive Mesothelioma
      • 100 Questions & Answers about Mesothelioma (Free Book)
      • Symptoms
      • Diagnosis
      • Prognosis
      • Life Expectancy
    • Types
      • Pleural
      • Peritoneal
      • Epithelioid
      • Sarcomatoid
      • Biphasic
    • Stages
      • Stage 1
      • Stage 2
      • Stage 3
      • Stage 4
    • Additional Information
      • Causes
      • Asbestos and Its Dangers
      • Facts
      • Support
      • Financial Compensation
      • FREE Mesothelioma Packet
  • Treatment
    • Treatment Options
      • Surgery
      • Chemotherapy
      • Radiation Therapy
      • Multimodal Therapy
      • Medications
      • Palliative Treatment
    • Find Top Doctors
      • Doctors
      • Treatment Centers
      • Treatment & Doctors Near You
      • New Treatments
      • Care Providers
      • Clinical Trials
      • Costs
  • Asbestos Trusts
  • Compensation
  • Veteran Assistance
    • Mesothelioma and Veterans
      • VA Claims for Mesothelioma
      • Vietnam Veterans
    • Military Branches and Asbestos
      • Navy Veterans
      • Navy Ships
      • Marine Corps Veterans
      • Army Veterans
      • Air Force Veterans
      • U.S. Coast Guard
  • Surviving Mesothelioma
  • About Us / Contact
  • Home
  • ›
  • Malignant Mesothelioma
  • ›
  • Types
  • ›
  • Cell Types
  • ›
  • Heterologous
Page Updated: June 24, 2022

Heterologous Mesothelioma

Pinar Kanlikilicer Page Medically Reviewed and Edited by Pinar Kanlikilicer, PhD

FREE Mesothelioma Packet

Fact Checked

This page has been fact checked by a PhD who specializes in cancer research. Sources of information are listed at the bottom of the article.

FREE Mesothelioma Packet

We make every attempt to keep our information accurate and up-to-date.

Please Contact Us with any questions or comments.

Heterologous mesothelioma is a rare cell sub-type of mesothelioma, in which the tumor contains cells from other parts of the body, such as bone tissue.[1][2] Very few cases have been studied, but the symptoms, diagnosis, treatment, and prognosis are similar to other types of mesothelioma.

FREE Mesothelioma Packet

What Is Heterologous Mesothelioma?

There are three types of mesothelioma based on cell type:

  • Epithelial
  • Sarcomatoid
  • Biphasic

Within these types, experts place subtypes, some of which are so rare experts only know of a few cases. Among these rare mesothelial cells is the heterologous type.

Heterologous can be any type, but it most often occurs in patients with the sarcomatoid cell type. Heterologous means that the tumors contain cells of other types of tissue, not just mesothelium cells. For instance, some heterologous mesothelioma tumors contain bone cells.

Facts About Heterologous Mesothelioma

Though information is scant, what we do know about heterologous mesothelioma comes from studies of individuals with tumors that have heterologous characteristics.[3] In one review of twenty-seven individuals:[4]

  • Eight-nine percent had pleural mesothelioma
  • The remaining 11% were diagnosed with peritoneal mesothelioma
  • Only 7% of patients were women
  • The median age was 68
  • Most patients were diagnosed with sarcomatoid or biphasic mesothelioma
  • Just one had epithelial mesothelioma

Cell types found in heterologous mesothelioma tumors included cartilage, bone cells, and muscle cells. The ratio and combination of cell types present in the tumor varied by patient. Some had just one unusual cell type while others had multiple.

The survival rate was low among these patients but consistent with other sub-types of sarcomatoid mesothelioma, the most aggressive form of the disease. Median survival for patients with heterologous mesothelioma was found to be six months after diagnosis.[4]

What Causes Heterologous Mesothelioma?

Like other types of mesothelioma, heterologous mesothelioma is associated with asbestos exposure.[4] Why cell types from other parts of the body end up in these tumors is not understood.

Early studies suggest it may be caused by a process called cellular differentiation. Cellular differentiation is a normal process that allows cells to adapt and specialize to perform certain functions.

Differentiated cells change to complete a job; however, after morphing they are typically unable to divide. They simply die after completing the job.

Cellular differentiation in cancer cells and tumors is atypical; however, healthy mesothelium cells are known to have the capacity to differentiate, sometimes changing into connective tissue. This may explain what happens in people diagnosed with heterologous mesothelioma.

Diagnosing Heterologous Mesothelioma

Diagnosis and treatment of this very rare type of mesothelioma follow the same guidelines as other types. Proper diagnosis includes a physical examination of symptoms, an imaging scan, and a biopsy. The imaging scan usually finds some abnormal tissue types. Then a biopsy will determine if it is cancerous.

During a biopsy, a thin needle is used to extract a sample of tissue or fluid. If the tumor is difficult to reach, surgery may be required to obtain a sample.

A pathologist then examines the sample under a microscope. By examining the cells, he or she can determine if they are malignant, what sub-type they are, and if they originated in the mesothelium.

For rare sub-types, pathologists may use immunohistochemistry for a more accurate diagnosis. This technique uses specific antibodies to detect antigens on the cancer cells. This can help pinpoint specific types of cells, like bone cells and cartilage, within a mesothelioma tumor.

IHC staining of various cytokeratins, calretinin, and desmin are performed in patients with heterologous mesothelioma tumors.

How Is Heterologous Mesothelioma Treated?

Treatment of heterologous mesothelioma is difficult because most are sarcomatoid.[1] By the time of diagnosis, this aggressive type of mesothelioma has often metastasized, continuing to spread rapidly through the body.

Surgery is not usually an option for sarcomatoid mesothelioma. Most patients will rely on chemotherapy, radiation, and other treatments to reduce pain and other symptoms. Treatment for this type is mostly palliative.

Generally, radiation and chemotherapy are used to shrink tumors, helping the patient feel more comfortable. Other treatments may also help patients feel more comfortable for their remaining time. These treatments include pain medication and draining fluid from around the lungs or in the abdomen.

Although surgery isn’t typically used for sarcomatoid types, a case study of a man with heterologous mesothelioma showed some positive results with trimodal therapy.

Doctors diagnosed the 69-year-old man with pleural heterologous mesothelioma. He underwent pneumonectomy surgery and received follow-up chemotherapy and intensity-modulated radiation therapy.

The man survived 12 months after trimodal therapy and still showed no recurrence in the chest cavity where surgeons removed tumors. Unfortunately, the cancer recurred in the peritoneum, leading to the man’s death.[5]

What Is the Prognosis?

Unfortunately, living 12 months after diagnosis and treatment is uncommon for most patients with sarcomatoid mesothelioma, the main cell type for heterologous tumors.

In one study of patients diagnosed with heterologous mesothelioma, the median survival time after diagnosis was only six months.

While this is a small group on which to base prognosis, it is safe to assume that the prognosis for this rare sub-type is poor. Treatment is generally palliative and used to relieve symptoms; although, it may extend the life of a patient for a short period.

Although the general prognosis is poor, it can be slightly better when the diagnosis is made early. Asbestos exposure is the number one risk factor for developing mesothelioma.

For this reason, anyone who has been exposed should be aware of the signs and receive regular screening. This gives patients the best chance of receiving treatment that will make a difference.

If you were diagnosed with heterologous mesothelioma, you may have legal rights to seek compensation. Because asbestos is the leading cause of this rare cancer, you may have been exposed without realizing the risks. Many people have suffered and died because of asbestos exposure.

Employers and manufacturers of asbestos-containing products are often to blame. Lawsuits, settlements, and trust funds are available to help mesothelioma patients seek compensation. Let a lawyer help you determine how to get the compensation to help cover medical and other expenses.

Get Your FREE Mesothelioma Packet

Page Medically Reviewed and Edited by Pinar Kanlikilicer, PhD

Pinar Kanlikilicer

Dr. Pinar Kanlikilicer has a PhD in Biomedical Engineering. She completed her 5-years of postdoctoral training in the Department of Experimental Therapeutics at MD Anderson Cancer Center. She is currently working in the field of cancer as a research scientist.

Learn more about Cancer Research Specialist Pinar Kanlikilicer, PhD
References
  1. Husain, A.N., et al. (2013, May). Guidelines for Pathologic Diagnosis of Malignant Mesothelioma. Arch. Pathol. Lab. Med. 137, 647-67.
    Retrieved from: https://www.archivesofpathology.org/doi/pdf/10.5858/arpa.2012-0214-OA
  2. Medical Dictionary. (n.d.). Heterologous Tumor.
    Retrieved from: https://medical-dictionary.thefreedictionary.com/heterologous+tumor
  3. Chave, G., Chalabreysse, L., Picaud, G., Blineau, N., Loire, R., Thivolet, F., Berthezene, Y., Douek, P., and Marchand, B. (2002, April). Malignant Pleural Mesothelioma with Osteoblastic Heterologous Elements CT and MR Imaging Findings. American Journal of Roentgenology. 178(4), 949-51.
    Retrieved from: https://www.ajronline.org/doi/full/10.2214/ajr.178.4.1780949
  4. Klebe, S., Mahar, A., Henderson, D.W., and Roggli, V.L. (2008, September). Malignant Mesothelioma With Heterologous Elements: Clinicopathological Correlation of 27 Cases and Literature Review. Mod. Pathol. 21(9), 1084-94.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/18587319
  5. Itano, H., Takeda, T., Yamada, T., Koide, M., and Kobayashi, T. (2020, August). Heterologous Sarcomatoid Pleural Mesothelioma with Osteosarcomatous Differentiation: A Report of Autopsy Case That Accomplished Trimodality Therapy and Review of the Literature. Gen. Thorac. Cardiovasc. Surg. 68(8), 871-9.
    Retrieved from: https://pubmed.ncbi.nlm.nih.gov/31372931/
View All References

Site Navigation

Home
Malignant Mesothelioma
How to Survive Mesothelioma
100 Questions & Answers about Mesothelioma (Free Book)
Surviving Mesothelioma - Beating the Odds (Free Book)
FREE Mesothelioma Packet
Symptoms
Shortness of Breath
Cough
Night Sweats and Fever
Weight Loss
Pain
Difficulty Swallowing
Fatigue and Muscle Weakness
Gastrointestinal Complications
Diagnosis
Pathology
Staging
Stage 1
Stage 2
Stage 3
Stage 4
Metastasis and Progression
Brain Metastasis
Biopsy
miRview Test
Imaging
Fine Needle Aspiration Biopsy in Mesothelioma
Biomarkers and Blood Tests
Calretinin
Prognosis
Remission
Recurrence
Death Rate
Life Expectancy
Search for a Mesothelioma Cure
Types
Pleural
Peritoneal
Epithelioid
Sarcomatoid
Biphasic
Pericardial
Testicular
Cell Types
Rare Subtypes of Mesothelioma
Deciduoid
Desmoplastic
Heterologous
Lymphohistiocytoid
Well-Differentiated Papillary
Tubulopapillary
Small Cell
Benign
Adenomatoid
Cystic
Unresectable
Localized
Idiopathic
Omental
Causes
Risk Factors
Latest Research
Genetic Components
Incidence
Latency Period
Mesothelioma Tumor
Health Insurance Coverage
Related Conditions
Immunodeficiency Disorders
Cholangiocarcinoma
Atelectasis
Pleural Plaques
Pleural Thickening
Pleural Effusion
Peritoneal Effusion (Ascites)
Mesothelial Hyperplasia and Proliferation
Pleuritis and Pleurisy
COPD
Anemia
Breast Cancer
Prevention
Complications
Misdiagnosis
Mesothelioma Commercial
Talcum Baby Powder
Lawyer
Lawsuits
Class Action Lawsuits
Settlements
Simian Virus 40
Differences From Other Cancers
Lung Cancer
Women
Children and Young Adults
Unknown Asbestos Exposure
Mesothelioma Without Asbestos
Cause of Death
Facts 
History
Awareness
Government and Research
National Mesothelioma Virtual Bank
Support
What to Expect
Living with Mesothelioma
Help a Loved One
Wrong and Right Things to Say
Caregivers
Financial Tips
Faith
Nutrition and Lifestyle
Intimacy
Mesothelioma and Fertility in Men
Fertility in Women with Mesothelioma
Emotional Health
COVID-19
Assisted Living
Hospice Care
Dying from Mesothelioma
Mourning
Coping Guide for Children
End-of-Life Decisions
Mesothelioma Awareness Day
Compensation for Victims
Lawyer
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington D.C.
Washington
West Virginia
Wisconsin
Wyoming
Lawsuit
Settlements
Statute of Limitations
Treatment
Surgery
Side Effects
Pneumonectomy
Extrapleural Pneumonectomy
Lobectomy
Pleurectomy/Decortication
Post Op Care
Pleurectomy/Decortication vs. Extrapleural Pneumonectomy
Peritonectomy/Cytoreductive Surgery
Thoracotomy
Thoracoscopy
Pericardiectomy
Wedge Resection
Pleurodesis
Pericardiocentesis
Prosthetics
Paracentesis
Thoracentesis
Chemotherapy
Side Effects
Heated Intraperitoneal
Radiation Therapy
Side Effects
Intensity-Modulated
Brachytherapy
Proton Therapy
Image-Guided
External Beam
Three-Dimensional
Multimodal Therapy
New Treatments
SMART Protocol
Gene Therapy
Suicide Gene Therapy
Tumor-Based p53 Therapy
Cryotherapy for Mesothelioma
Tumor Treating Fields
MicroRNA
Palliative Treatment
Osteopathic
Doctors
Treatment Centers
Treatment & Doctors Near You
Mesothelioma Experts
Medications
Alimta (pemetrexed)
Adriamycin (doxorubicin)
Avastin (bevacizumab)
Cytoxan (cyclophosphamide)
Gemzar (gemcitabine)
Keytruda (Pembrolizumab)
Mitomycin
Navelbine (vinorelbine)
Opdivo (nivolumab) and Yervoy (ipilimumab)
Paraplatin (carboplatin)
Platinol (cisplatin)
Rheumatrex (methotrexate)
Sutent (sunitinib)
Taxol (paclitaxel)
Medical Marijuana
Care Providers
Clinical Trials
Anetumab Ravtansine
Atezolizumab
Chimeric Antigen Receptor (CAR) T-Cell
Durvalumab
Immunotoxin
Interferon Alfa-2b
Onconase (Ranpirnase)
VISTA Protein
Costs
Immunotherapy
Nanotechnology
Hyperbaric Oxygen Therapy
Home Medical Equipment
HMGB1 Secretion
Photodynamic Therapy
Targeted Therapies
Apoptosis
Stem Cells
Lung Transplantation
Body-Based Therapies
Alternative Therapies
Paul Kraus’s Method
Doctors and Treatment in Canada
Asbestos Trusts
Veterans
VA Claims for Mesothelioma
Vietnam Veterans
Military Branches and Asbestos
Navy Veterans
Navy Ships
Aircraft Carriers
Battleships
Destroyers
Asbestos on Navy Cruisers
Submarines
Amphibious Ships
Minesweepers
Auxiliary Ships
Marine Corps Veterans
Army Veterans
Air Force Veterans
U.S. Coast Guard
Asbestos
Occupational Exposure
Construction Workers
Shipyard Workers
Ship Repair
Steel Mill Workers
Industrial Workers
Boiler Workers
Power Plant Workers
Firefighters
Automotive Workers
Roofers
Oil Refineries
Mining
Transportation Industry
Machine Operators
Farmers and Agricultural Workers
Migrant Workers
Electrical Wiring
Labor Unions
Prisons
Chimneys, Furnaces, and Wood Stoves
Fiberglass Connection to Mesothelioma
Home Remodeling
School Buildings, Teachers
For Tech Students
Cancer
Lung Cancer
Pleural Based Cancers
Ovarian Cancer
Ovarian Cancer Lawsuits
Companies That Used Asbestos
Awareness and Education
Types of Asbestos & Mesothelioma Risk
Asbestosis
Interstitial Lung Disease
Smoking
Asbestos Ingestion
Exposure in a Natural Disaster
Ban Asbestos
Libby, Montana
Recycling Asbestos
Asbestos Detection
Legal Information by State
Canada
Mexico
United Kingdom
Australia
  • Malignant Mesothelioma
    • Treatment
    • Asbestos Trusts
  • Compensation
    • Veteran Assistance
    • Surviving Mesothelioma
  • FREE Mesothelioma Packet
    • Mesothelioma News
    • About Us / Contact
  • Privacy Policy
    • Disclaimer
    • Editorial Guidelines and Standards
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.
The information provided by Mesothelioma.net is not a substitute for professional medical advice, diagnosis or treatment.

Mesothelioma.net

5430 LBJ Freeway Suite 1200
Dallas, Texas 75240

Serving mesothelioma victims nationwide

1-800-692-8608

  • facebook
  • twitter
© 2022 Mesothelioma.net